BCI, RCR, and SKE are very close to being sold.SKE the worst down 16% on purchase and almost 1% of total portfolio. Dividend coming up soon.No buys have been generated over the last few days.
OCC Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil